Skip to main content
. 2024 Oct 31;14(11):e70117. doi: 10.1002/brb3.70117

TABLE 1.

Basic characteristics of included studies.

Study (year) Design Location Intervention (n) Recovery phase (months) Duration (weeks) Training length (per session) (min) Type of robotic Outcome measures
Treatment Control
Yuan et al. (2023) RCT China RT (23) CR (23) ≤ 6 3 60 End‐effector FMA‐UE, MBI
Şenocak et al. (2023) RCT Turkey RT (19) CR (22) ≤ 6 6 60 End‐effector FMA‐UE
Taravati et al. (2022) RCT Turkey RT (17) CR (20) > 6 4 30 End‐effector FMA‐UE, MAS
Ma et al. (2022) RCT China RT (10) CR (9) ≤ 6 4 90 Exoskeleton FMA‐UE, ARAT
Hsu et al. (2022) RCT China RT (17) CR (15) > 6 9 40 Exoskeleton FMA‐UE, MAS
Guo et al. (2022) RCT China RT (10) CR (10) > 6 2 60 Exoskeleton FMA‐UE, MAS
Frisoli et al. (2022) RCT Italy RT (11) CR (11) > 6 6 45 End‐effector FMA‐UE
Coskunsu et al. (2022) RCT Turkey RT (11) CR (19) ≤ 6 3 60 End‐effector FMA‐UE, ARAT
Singh et al. (2021) RCT India RT (12) CR (11) > 6 4 45 Exoskeleton FMA‐UE, MBI, MAS
Lee et al. (2021) RCT China RT (14) CR (10) > 6 6 60 End‐effector FMA‐UE, MBI
Kim et al. (2021) RCT Korea RT (23) CR (24) > 6 4 30 End‐effector FMA‐UE, MAS
Jiang et al. (2021) RCT China RT (23) CR (22) ≤ 6 2 30 Exoskeleton FMA‐UE, MBI
Chinembiri et al. (2021) RCT China RT (20) CR (25) ≤ 6/> 6 6 50 End‐effector FMA‐UE, MBI
Chen et al. (2021) RCT China RT (10) CR (10) ≤ 6 4 45 Exoskeleton FMA‐UE, ARAT, MBI
Ranzani et al. (2020) RCT Switzerland RT (14) CR (13) ≤ 6 4 45 End‐effector FMA‐UE
Sun (2018) RCT China RT (38) CR (32) ≤ 6 4 30 Exoskeleton FMA‐UE, MBI
Lee, Lee, and Lee (2018) RCT Korea RT (15) CR (15) > 6 8 30 Exoskeleton FMA‐UE, MBI
Zhang (2016) RCT China RT (6) CR (6) > 6 4 20 End‐effector FMA‐UE, MAS

Abbreviations: ARAT, Action Research Arm Test; CR, conventional rehabilitation; MAS, modified Ashworth Scale; MBI, Modified Barthel Index; RCT, randomized controlled trial; RT, robotic therapy.